GREEN ALPHA ADVISORS, LLC – CRISPR Therapeutics AG Transaction History
GREEN ALPHA ADVISORS, LLC portfolio value:
$1.79M
portfolio value
GREEN ALPHA ADVISORS, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -87.97% | -200.82K shares | -12.07M | $65.35 | 27.46K |
| Q2 2022 | share | Increase | +794.08% | 202.75K shares | 12.27M | $60.77 | 228.28K |
| Q1 2022 | share | Increase | +48.80% | 8.37K shares | 303K | $62.77 | 25.53K |
| Q4 2021 | share | Increase | +14.99% | 2.23K shares | -370K | $78.85 | 17.15K |
| Q3 2021 | share | Increase | +17.42% | 2.21K shares | -387K | $111.93 | 14.92K |
| Q2 2021 | share | Increase | +87.05% | 5.91K shares | 1.22M | $161.89 | 12.70K |
| Q1 2021 | share | Increase | +6.96% | 442 shares | -145K | $121.85 | 6.79K |
| Q4 2020 | share | Increase | 0.00% | 6.35K shares | 973K | $153.11 | 6.35K |